PRODUCT LITERATURE

Interim report of the favipiravir (Avigan®) observational study.

---

The new coronavirus (SARS-CoV-2) was initially identified from patients with pneumonia of unknown cause in Hubei Province, People’s Republic of China in December 2019. The virus has since spread globally and infected over four and a half million people as of
May 15, 2020. In Japan, over 16,000 have been infected, and over 800 of them have died from the new coronavirus infection (COVID-19)

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Avigan
Favipiravir

Specific Detail Info

Favipiravir Observational Study Group

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment